The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: Importance of mRNA half-life regulation

被引:44
作者
Vockerodt, M
Pinkert, D
Smola-Hess, S
Michels, A
Ransohoff, RM
Tesch, H
Kube, D [1 ]
机构
[1] Univ Gottingen, Fachbereich Humanmed, Zentrum Innere Med, Hamatol Onkol Abt, D-37090 Gottingen, Germany
[2] Univ Gottingen, Zentrum Kinderheilkunde & Jugendmed, Abt Padiat 1, D-37090 Gottingen, Germany
[3] Univ Cologne, Innere Med Abt 1, D-5000 Cologne 41, Germany
[4] Univ Cologne, Inst Virol, D-5000 Cologne 41, Germany
[5] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA
关键词
EBV-LMP1; IP-10; mRNA stability;
D O I
10.1002/ijc.20759
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The latent membrane protein 1 (LMP1) of Epstein-Barr Virus (EBV) is the main inducer of immuno-modulatory molecules affecting growth and survival of EBV-infected cells. However, the network of signalling pathways involved remains to be elucidated. Here we show that LMP1 may regulate cellular genes like IFN-gamma-inducible protein-10 kDa (IP-10) not only through transcriptional but also post-transcriptional mechanisms. LMP1-mediated IP-10 expression is independent from IFN-gamma, TNF-alpha or IL-18. Transcriptional activation of IP-10 by LMP1 or CD40 stimulation depends on an NF-KB motif within the proximal 435 bp fragment. Carboxy-terminal activating regions 1 or 2 of LMP1 are sufficient to direct IP-10 promoter activation. IP-10 induction is inhibited by blockade of p38/SAPK2 with SB 202190, which results in decreased IP-10 mRNA half-life without affecting IP-10 promoter activity. Thus, LMP1-mediated p38/SAPK2 activation regulates transcript stability. This new mechanism of gene regulation demonstrates the potential of the oncoprotein LMP1 to orchestrate a network of signalling pathways at different regulatory levels including mRNA stability. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:598 / 605
页数:8
相关论文
共 42 条
[1]  
Altenburg A, 1999, J IMMUNOL, V162, P4140
[2]   ARED 2.0: an update of AU-rich element mRNA database [J].
Bakheet, T ;
Williams, BRG ;
Khabar, KSA .
NUCLEIC ACIDS RESEARCH, 2003, 31 (01) :421-423
[3]   Signalling events regulating lymphoid growth and survival [J].
Brennan, P .
SEMINARS IN CANCER BIOLOGY, 2001, 11 (06) :415-421
[4]   Mechanism of action of a novel latent membrane protein-1 dominant negative [J].
Brennan, P ;
Floettmann, JE ;
Mehl, A ;
Jones, M ;
Rowe, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :1195-1203
[5]   EPSTEIN-BARR-VIRUS TRANSFORMATION INDUCES LYMPHOCYTES-B TO PRODUCE HUMAN INTERLEUKIN-10 [J].
BURDIN, N ;
PERONNE, C ;
BANCHEREAU, J ;
ROUSSET, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :295-304
[6]   p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes [J].
Dean, JLE ;
Brook, M ;
Clark, AR ;
Saklatvala, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (01) :264-269
[7]  
Devergne O, 1996, MOL CELL BIOL, V16, P7098
[8]   Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2 [J].
Eliopoulos, AG ;
Blake, SMS ;
Floettmann, JE ;
Rowe, M ;
Young, LS .
JOURNAL OF VIROLOGY, 1999, 73 (02) :1023-1035
[9]   Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production [J].
Eliopoulos, AG ;
Gallagher, NJ ;
Blake, SMS ;
Dawson, CW ;
Young, LS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (23) :16085-16096
[10]   LMP1 structure and signal transduction [J].
Eliopoulos, AG ;
Young, LS .
SEMINARS IN CANCER BIOLOGY, 2001, 11 (06) :435-444